Aims Matrix metalloproteinase (MMP)-2 contributes to myocardial oxidative stress injury by degrading sarcomeric and cytoskeletal proteins in cardiomyocytes. Glycogen synthase kinase (GSK)-3b is dysregulated during oxidative stress and is susceptible to proteolytic cleavage. Here we determined whether GSK-3b is a MMP-2 substrate as a result of oxidative stress. Methods and results MMP-2 and GSK-3b were incubated and the cleavage fragments were identified by immunoblotting and silver stain. The intact protein and its primary cleavage fragment were subjected to trypsin digestion and the resultant peptides were analysed by LC-MS/MS. GSK-3b kinase activity was measured using a peptide substrate and [g-32 P]-ATP. Oxidative stress in H9c2 cardiomyoblasts was induced by H 2 O 2 and the levels and activities of MMP-2 and GSK-3b were measured. Incubation of 47 kDa GSK-3b with MMP-2 resulted in the time-and concentration-dependant cleavage of GSK-3b as seen by appearance of an 30 kDa fragment. MS analysis and Mascot database search yielded a peptide with an amino acid sequence of GSK-3b lacking the N-terminal region. GSK-3b kinase activity was significantly increased upon incubation with MMP-2 which was abrogated by the MMP inhibitor GM-6001. H 2 O 2 challenge of H9c2 cardiomyoblasts significantly increased the activity and level of MMP-2, reduced the level of GSK-3b, and significantly increased GSK-3b kinase activity. Both the loss of intact GSK-3b and increase in its kinase activity were reduced with MMP inhibitors. MMP-2 pulldown assays in H9c2 cell lysates showed the association of MMP-2 with GSK-3b. Conclusion GSK-3b may be a target of MMP-2 and its cleavage by MMP-2 enhances its kinase activity. MMP-2 may cleave off the N-terminal of GSK-3b where the inhibitory phosphorylation of serine-9 occurs. MMP-2-mediated augmentation of GSK-3b kinase activity may contribute to cardiac injury resulting from enhanced oxidative stress.
Introduction
Matrix metalloproteinases (MMPs) are a family of zincdependent endopeptidases best known for their actions in extracellular remodelling which include physiological processes such as embryogenesis, angiogenesis, and wound healing as well as pathological conditions such as tumour cell invasion, 1 inflammation, 2 arteriosclerosis, 3 and cardiac ischaemic injury. 4, 5 Recently, we and others have reported that MMP-2 co-localizes with and is responsible for the degradation of the sarcomeric proteins troponin I 6, 7 and myosin light chain-1 8 and the cytoskeletal protein a-actinin 9 in myocardial oxidative stress injury resulting either from ischaemia-reperfusion, pro-inflammatory cytokine stress, 10 or infusion of peroxynitrite. 11 MMP inhibitors prevented the oxidative stress mediated cardiac contractile dysfunction in the above models 6, 8, 10, 11 and also protected isolated cardiomyocytes from oxidative stress-induced contractile dysfunction in the absence of extracellular matrix proteins. 12 One of the earliest events following enhanced oxidative stress within the cardiomyocyte is the activation of MMP-2 and subsequent proteolysis of its susceptible intracellular targets (for review see 5 ) .
Glycogen synthase kinase (GSK)-3 is a ubiquitously expressed serine/threonine kinase in eukaryotes that has several functions including the regulation of glycogen metabolism. 13 Two mammalian GSK-3 isoforms, a (51 kDa) and b (47 kDa), are encoded by distinct genes. Although highly homologous within their kinase domains (98% identity), the isoforms of GSK-3 are not functionally identical. More recently it has become evident that GSK-3b is a crucial component of many cellular functions regulating apoptosis, cell cycle, cell polarity, and migration and gene expression, to name a few. 13 This multitasking is achieved by the many substrates phosphorylated by GSK-3b and the convergence by GSK-3b on many regulatory intracellular signalling pathways. 14 activity is regulated by phosphorylation of its regulatory serine-9 (Ser-9) residue by phosphatidylinositol 3-kinase (PI3K)/Akt signalling, resulting in loss of kinase activity. 13, 15 Inhibition of GSK-3b activity has been shown to be cardioprotective also by reducing apoptosis in the ischaemic heart. 16 A GSK inhibitor was reported to reduce infarct size when administered prior to reperfusion. 17 Recent literature indicated the susceptibility of GSK-3b to proteolytic cleavage by the calcium-activated protease calpain-1. 18 We therefore decided to investigate the possible interaction between MMP-2 and GSK-3b in light of their common involvement in cardiac injury. In the present study, we demonstrate that GSK-3b is a substrate of MMP-2 for proteolytic cleavage and this cleavage by MMP-2 leads to augmented GSK-3b kinase activity in cardiomyoblasts exposed to a known activator of MMP-2, hydrogen peroxide. 19 
Methods
Human recombinant MMP-2 and calpain-1 were purchased from Calbiochem (Gibbstown, NJ, USA) while GSK-3b and N-terminally GST-tagged GSK-3b (GST-GSK-3b) were from R&D Systems (Minneapolis, MN, USA). The commercial antibodies used were: anti-GSK-3a/b (Invitrogen, Carlsbad, CA, USA), anti-GSK-3b, anti-Ser-9-pGSK-3b, anti-GST (Cell Signaling Technology, Beverly, MA, USA), anti-MMP-2 (Chemicon, Temecula, CA, USA), and anti-GAPDH (Calbiochem). GSK-3b peptide substrate used to determine GSK-3b kinase activity was from Biomol Research Laboratory (Plymouth Meeting, PA, USA). Unless otherwise specified, other reagents used were obtained from Sigma-Aldrich (Oakville, ON, USA) or Fisher Scientific (Nepean, ON).
In vitro cleavage assays
Recombinant GSK-3b (47 kDa) was incubated with 64 kDa MMP-2 at different enzyme-substrate molar ratios at 308C for various time periods in 50 mM Tris buffer (5 mM CaCl 2 , 150 mM NaCl, pH 7.6) as reported for MMP-2-mediated cleavage of troponin I with minor modifications. 6 Upon completion of the incubation, the samples were heated for 5 min at 958C, electrophoresed on 10 or 12% SDSpolyacrylamide gels and subjected to either silver staining using a Silverquestw kit (Invitrogen) or immunoblotted following membrane transfer using either GSK-3a/b or anti-Ser-9-pGSK-3b antibodies. To demonstrate the specificity of MMP-mediated effects, certain incubations were performed in the presence of the MMP inhibitor GM-6001 (300 nM, Calbiochem). The densitometric analysis of protein bands was performed using Quantity One software from BioRad. In a separate set of experiments, calpain-1 was incubated with GSK-3b at 308C for 30 min in 50 mM Tris buffer (50 mM NaCl, 5 mM CaCl 2 , 1 mM EDTA, 1 mM EGTA, and 5 mM b-mercaptoethanol, pH 7.4) for comparison purposes.
In-gel trypsin digestion of native GSK-3b and its 30 kDa cleavage product was carried out after resolving the incubation mixture of MMP-2 and GSK-3b by SDS-PAGE and visualizing proteins with Coomassie stain. The bands were excised and subjected to trypsin digestion. 20 The mixture of extracted peptides from the trypsin digest was analysed by LC-MS/MS. Analysis was performed on a LCQ Deca XP iontrap mass spectrometer with a nanospray ionization source which was in-line with an Agilent 1100 nano-HPLC. Mass spectrometry data were analysed by searching the Mascot database 21 to identify the proteins.
To more closely identify the cleavage site of GSK-3b, N-terminal glutathione S-transferase (GST)-tagged GSK-3b (73 kDa) was incubated with MMP-2 as mentioned above and subsequently immunoblotted for GST or GSK-3b using anti-GST or anti-GSK-3b, respectively.
GSK-3b activity assays
An aliquot from the in vitro cleavage reaction mixture was mixed with kinase assay buffer (5 mM MOPS, 2.5 mM b-glycerophosphate, 5 mM MgCl 2 , 1 mM EGTA, 0.4 mM EDTA, 0.05 mM dithiothreitol, and 50 mg/mL of bovine serum albumin) and GSK-3b peptide substrate (H-Arg-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-pSer-Pro-Gln-Leu-OH, Biomol) as described previously. 22 Samples were incubated for 15 min at 308C in the presence of 50 mM ATP (1000 cpm/pmol of g-32 P-ATP). The phosphorylation of the peptide substrate was quantified by liquid scintillation counting. Some experiments contained the MMP inhibitor GM-6001 to demonstrate the specificity of MMP-2 activity.
Dephosphorylation assays
GSK-3b was dephosphorylated with serine specific l-phosphatase (New England BioLabs, Beverly, MA, USA) in a buffer containing 50 mM Tris pH 7.8, 300 mM NaCl, 10% glycerol, 0.5 mM MnCl 2 , and 5 mM dithiothreitol for 30 min at 308C to remove the phosphorylation that occurs during its expression. The dephosphorylation of the protein was confirmed by immunoblotting using the phospho-specific antibody, anti-Ser-9-pGSK-3b, and the anti-GSK-3b antibody as a loading control. 18 The control and dephosphorylated GSK-3b were incubated with MMP-2 as above to effect its cleavage and the incubates were subsequently subjected to the kinase assay.
Cell lines and culture
The rat embryonic ventricular cardiomyoblast cell line H9c2 was maintained as described previously 23 in Dulbecco's Modified Eagle Medium (Invitrogen) with 5.5 mM glucose supplemented with 10% (v/v) foetal bovine serum and 1% penicillin/streptomycin (v/v). Cells were routinely grown to 80% confluence in 75 cm 2 flasks at 378C in an atmosphere of 5% CO 2 prior to passage and seeding for experiments. Twenty-four hours prior to experiments, the cells were changed to serum-free media. For the induction of oxidative stress, cells were exposed to 50 mM H 2 O 2 for 5 h in the presence or absence of the MMP inhibitors GM-6001 (1 mM) or ONO-4187 (1 mM).
Immunoblot analysis
Cultured cells were harvested in lysis buffer (20 mM Tris-HCl pH 7.4, 50 mM NaCl, 50 mM NaF, 5 mM sodium pyrophosphate, 250 mM sucrose, and 0.5% Triton X-100) including protease inhibitors cocktail (P8340, Sigma) and phosphatase inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA) and lysed by aspirating the cells through a 26 gauge needle three times. Cell debris was removed by centrifuging the cell lysate at 100 g for 10 min at 48C. Protein concentration was measured using BioRad protein assay reagent. Equal protein samples of the cell lysates were electrophoresed on 10% SDS-polyacrylamide gels under reducing conditions and then transferred onto polyvinylidene fluoride membranes. The membranes were blocked with 5% skim milk in Tris-buffered saline (10 mM Tris-HCl, 150 mM NaCl, pH 7.5) containing 0.05% Tween 20, and then incubated at 48C overnight with primary antibody raised against either GSK-3b or MMP-2. After washing, the blots were coupled with the peroxidase-conjugated secondary antibodies, washed, and then developed using the ECL detection kit (GE Healthcare UK Limited, Buckinghamshire, UK) according to the manufacturer's instructions. The membranes were stripped using Restorew western blot stripping buffer (Thermoscientific, Rockford, IL, USA) and re-probed for glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The intensity of protein bands was quantified densitometrically, and the value was estimated relative to that for GAPDH as a protein loading control.
GSK-3b activity assays in cell lysates
In order to measure GSK-3b activity in cell lysates, they were incubated for 15 min at 308C with 10 mM GSK-3b peptide substrate (Biomol) in the presence of 50 mM ATP (1000 cpm/pmol of [g-32 P]ATP, PerkinElmer Life Sciences) in 25 mM Tris, pH 7.5, 1 mM dithiothreitol and 10 mM MgCl 2 . The assays were stopped by spotting aliquots onto P81 phosphocellulose paper (Millipore, Billerica, MA, USA). The phosphorylation of the peptide substrate was quantified by liquid scintillation counting.
Gelatin zymography
H9c2-conditioned media were concentrated by ultra-filtration with centrifugal filter devices (Amicon Ultra, Millipore Corporation) and then subjected to gelatin zymography as previously described. 23, 24 Briefly, concentrated conditioned media (1 mg protein/lane) was applied to an 8% polyacrylamide gel copolymerized with 2 mg/mL of gelatin. After electrophoresis, gels were washed three times for 20 min each with 2.5% Triton X-100 to remove sodium dodecyl sulfate. Then gels were rinsed with incubation buffer containing 50 mM Tris-HCl (pH 7.6), 5 mM CaCl 2 , 150 mM NaCl, and 0.05% w/v NaN 3 and incubated with the same incubation buffer at 378C for 5 h. Recombinant MMP-2 was used as a standard. The gels were stained in 2% Coomassie Brilliant Blue G-250, 25% methanol, and 10% acetic acid for 2 h and then destained for 1 h in 2% methanol/ 4% acetic acid (v/v). Zymograms were scanned using a calibrated densitometer GS 800 (BioRad, Mississauga, ON) and the band intensities were analysed by densitometric analysis using the ImageJ software program (NIH).
Cell viability
Cardiomyoblast viability was measured using MTT assay based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide by mitochondrial reductases in live cells. Cells were seeded at a density of 6000 cells per well in 96-well plates and challenged with various concentrations of H 2 O 2 for 5 h. After which, 50 mL of MTT reagent (final concentration: 500 mg/mL) was added. After 4 h of incubation at 378C, the cell supernatants were discarded, MTT crystals were dissolved with dimethyl sulfoxide and the absorbance was measured at 560 nm. All assays were performed in triplicate. Percent cytotoxicity was defined as the relative absorbance of treated vs. untreated control cells.
Co-immunoprecipitation study
Lysates were prepared from untreated H9c2 cells and pre-cleared using Protein-A Sepharose bead suspension (Amersham Biosciences, Piscataway, NJ, USA) by incubating for 60 min at 48C and subsequently incubating with monoclonal anti-MMP-2 (Chemicon) or with mouse monoclonal IgG in lysis buffer overnight at 48C. On the following day, Protein-A Sepharose bead suspension was added and further incubated overnight at 48C. After centrifugation (12 000 Â g for 20 s), the pellet was washed three times in lysis buffer and once with wash buffer (50 mM Tris, pH 8). The final pellet was suspended in 30 mL of sample buffer heated to 958C for 3 min, centrifuged and the proteins were separated by SDS-PAGE followed by immunoblotting for GSK-3b.
Statistical analysis
Values are expressed as mean + SEM. The statistical significance of differences between the mean values was analysed by ANOVA followed by Tukey's post hoc test or Student's t-test, as appropriate. A P-value of less than 0.05 was considered to be significant. All statistical analyses were carried out using GraphPad w Prism software version 5.0 (GraphPad Software Inc., San Diego, USA).
Results

In vitro proteolytic cleavage of GSK-3b by MMP-2
Incubation of GSK-3b with MMP-2 resulted in cleavage fragments appearing as a doublet 30 kDa which were detected using GSK-3b antibody and also evidenced by silver staining ( Figure 1A) . As GSK-3b is known to be susceptible to cleavage by calpain-1 18 , we compared GSK-3b cleavage by this protease. In contrast to the results using MMP-2, the calpain-1 induced cleavage fragment appeared at a different molecular weight of 25 kDa compared with those produced by MMP-2 ( Figure 1A) . The MMP inhibitor GM-6001 (300 nM) completely inhibited MMP-2-mediated cleavage of GSK-3b, indicating the specificity of MMP-2 actions ( Figure 1B) . Proteolytic cleavage of GSK-3b by MMP-2 was also concentration-dependant as shown by the appearance of cleavage fragments as the MMP-2 to GSK-3b molar ratio was increased from 1:100 to 1:5 ( Figure 1C ). To further evaluate the time-dependant enzymatic reaction of MMP-2 on GSK-3b, MMP-2 and GSK-3b (1:5 molar ratio) were incubated at 308C and the reaction was stopped at the various time points until 240 min. The immunoblot for GSK-3b ( Figure 2 , upper panel) clearly shows that the 30 kDa cleavage product of GSK-3b began to appear within 5 min and this band grew in intensity over time. Interestingly, the immunoblot for S9-pGSK-3b (Figure 2 , lower panel) showed near complete disappearance of the mother band by 240 min, indicating the progression of the enzymatic reaction of MMP-2. The appearance of a band for the 30 kDa product in the S9-pGSK-3b immunoblot after 30-60 min incubation is likely due to cross-reactivity of the antibody with other GSK-3b epitopes as the quantity of the product increased.
To identify the amino acid sequence represented by the 30 kDa cleavage fragment of GSK-3b, both GSK-3b and this fragment were excised from the gels and subjected to in-gel digestion with trypsin, and the resulting peptides were analysed by LC-MS/MS. A search of Mascot database (www.matrixscience.com) identified the 30 kDa band as chain-A GSK-3b which lacked the initial 34 amino acids of the N-terminal region of GSK-3b. Further analysis of the peptides indicated that the first matching peptide sequence appeared from the 60th amino acid of the full length protein (Figure 3) .
Interestingly, when N-terminally GST-tagged GSK-3b (73 kDa) was incubated with MMP-2, the GST antibody detected a distinct fragment different from that detected by GSK-3b antibody, indicating N-terminal cleavage by MMP-2 (Figure 4 ).
Cleavage by MMP-2 augments GSK-3b kinase activity
To determine whether MMP-2-mediated cleavage of GSK-3b alters its kinase activity, GSK-3b was incubated at an MMP-2:GSK-3b molar ratio of 1:5 for 30 min at 308C and the kinase activity was then determined using g-32 P-ATP and a peptide substrate. In comparison to the significant increase in GSK-3b activity by calpain-1, GSK-3b kinase activity was also significantly increased upon incubation with MMP-2 ( Figure 5A ). However, no increase in the GSK-3b kinase activity was observed in incubates containing the MMP inhibitor GM-6001 (300 nM). When added after the incubation of MMP-2 and GSK-3b and before the kinase assay, GM-6001 had no effect on the MMP-2-mediated augmentation of GSK-3b kinase activity ( Figure 5A) . These data demonstrate that the GSK-3b fragments are catalytically active and also suggest that MMP-2-mediated proteolytic cleavage increases its kinase activity. Time and concentration course experiments revealed that MMP-2 mediates significant augmentation of GSK-3b kinase activity with only 5 min of incubation ( Figure 5B ) and a significant increase in kinase activity was observed starting with a MMP-2:GSK-3b molar ratio of 1:10 ( Figure 5C ).
MMP-2 increases GSK-3b activity akin to dephosphorylation of Ser-9 of GSK-3b
A well-established mechanism that increases GSK-3b activity involves the dephosphorylation of Ser-9 present in the N-terminal end of GSK-3b. 25 Using anti-Ser-9-pGSK-3b antibody, we detected phosphorylation of the Ser-9 residue in GSK-3b ( Figure 6A) . Interestingly, cleavage of GSK-3b with MMP-2 resulted in cleavage fragments seen both with anti-Ser-9-pGSK-3b antibody and with GSK-3b antibody ( Figure 6A ). Hence to further investigate the mechanism of MMP-2-mediated augmentation of GSK-3b activity, recombinant GSK-3b was dephosphorylated at Ser-9 using l-phosphatase. Dephosphorylation abolished Ser-9 phosphorylation that was confirmed by immunoblotting using anti-S9-pGSK-3b and anti-GSK-3b antibodies ( Figure 6A) . Either MMP-2 or l-phosphatase treatment increased GSK-3b activity to a similar extent and the combination treatment did not further enhance GSK-3b activity ( Figure 6B ).
H9c2 cell viability following H 2 O 2 treatment
We next examined the possible interaction of GSK-3b and MMP-2 in cultured H9c2 cardiomyoblasts. As H 2 O 2 is known to stimulate MMP-2 activity, 19 we subjected these cells to H 2 O 2 (25-1000 mM) for 5 h. The viability of H9c2 cells after H 2 O 2 exposure, measured using the MTT assay, indicated that H 2 O 2 exhibited a significant cytotoxicity to the cells only when applied at concentrations !100 mM (n ¼ 4, data not shown). We therefore used 50 mM H 2 O 2 as an oxidative stress challenge for all subsequent experiments with these cells.
H 2 O 2 increases MMP-2 levels and activity in H9c2 cells
As shown in Figure 7A , treatment of H9c2 cells with 50 mM H 2 O 2 significantly increased the cellular levels of MMP-2 when compared with control cells. Gelatin zymography of the conditioned medium indicated that MMP-2 activity was also significantly increased ( Figure 7B) . (A) Recombinant MMP-2 or calpain-1 was incubated with GSK-3b for 30 min at 308C (protease to GSK-3b molar ratio 1:5). Then GSK-3b activity was measured as described under experimental procedures. 'Control' represents GSK-3b activity obtained before MMP-2 treatment. *P , 0.05 vs. Control, n ¼ 4, One-way ANOVA followed by Tukey's post hoc test, # P , 0.05 vs. Control, Student's t-test, n ¼ 3. To indicate the specificity of MMP-2 activity, certain incubations contained the MMP inhibitor GM-6001 (300 nM), which inhibited the MMP-2-mediated increase in GSK-3b kinase activity. However, if GM-6001 was added after the proteolysis reaction it did not have any effect on GSK-3b kinase activity. In separate sets of assays, MMP-2-mediated cleavage increased GSK-3b kinase activity in both a time-(B, n ¼ 3) and concentration-dependant (C, n ¼ 3) manner. *P , 0.05 vs. Control.
H 2 O 2 decreases GSK-3b levels and increases its kinase activity in H9c2 cells
Treatment of H9c2 cells with H 2 O 2 for 5 h caused a significant decrease in cellular protein levels of GSK-3b compared with control cells; this reduction in GSK-3b was abrogated by treatment with the MMP inhibitors GM-6001 (1 mM) or ONO-4187 (1 mM) ( Figure 8A) . GSK-3b kinase activity was significantly increased after treatment of H9c2 cells with H 2 O 2 for 5 h ( Figure 8B) . Either of the inhibitors abolished the H 2 O 2 induced increase in GSK-3b kinase activity in these cells.
Co-immunoprecipitation reveals the association of MMP-2 with GSK-3b in H9c2 cells
H9c2 cell lysates were immunoprecipitated with either IgG or anti-MMP-2 antibodies. Immunoblot analysis of the precipitates prepared with anti-MMP-2, but not with IgG, showed a 47 kDa band corresponding to GSK-3b (Figure 9) , indicating the co-immunoprecipitation of GSK-3b with MMP-2.
Discussion
We have demonstrated for the first time that GSK-3b is cleaved following incubation with MMP-2 and this proteolytic cleavage of GSK-3b increased its kinase activity. In cardiomyoblasts subjected to H 2 O 2 , the MMP inhibitors GM-6001 or ONO-4187 prevented both the loss of GSK-3b content and augmentation of its kinase activity.
MMPs are traditionally known for their role in extracellular matrix remodelling. Increasing evidence reveals several alternative substrates and novel biological roles for these proteases. We and others have shown the intracellular localization of MMP-2 within cardiac myocytes. 6, 26, 27 MMP-2, a gelatinase prevalent in the cardiovascular system, can degrade such extracellular matrix proteins as type IV and all non-fibrillar collagens, fibronectin, elastin, and laminin. 28 However, recent studies reveal a growing number of novel non-matrix substrates and roles for this enzyme including the mediation of platelet aggregation 29 and vasoconstriction caused by cleaving big endothelin-1 to a novel vasoconstrictor 30 or by degradation of the vasodilator calcitonin gene-related peptide. 31 MMP-2 is also involved in the inflammatory process, as it cleaves monocyte chemoattractant protein-3. 32 As well, we have shown that MMP-2 copurifies with the thin myofilaments from cardiac myocytes and is colocalized with, and capable of, cleaving troponin I, 6 a regulatory protein of the actin-myosin contractile apparatus. The degradation of troponin I by MMP-2 occurs during myocardial ischaemia-reperfusion injury and contributes to the impairment in muscle contractility seen in early reperfusion. 6 Myocardial-specific overexpression of constitutively active MMP-2 results in contractile dysfunction at the sarcomeric level which includes the loss of troponin I. 7, 33 The many functions regulated by GSK-3b (through phosphorylation of numerous substrates) suggest that the activity of GSK-3b must be highly regulated. 15 Four key mechanisms have been identified that contribute to regulating the actions of GSK-3b in a substrate-specific manner. These include regulation by phosphorylation of GSK-3b itself, the subcellular localization of GSK-3b, the formation of protein complexes containing GSK-3b, and the phosphorylation state of GSK-3b substrates. The most welldefined regulatory mechanism is inhibition of the activity of GSK-3b by phosphorylation of the regulatory Ser-9 residue. The PI3K/Akt signalling pathway, activated in response to insulin and many other growth factors, is often a major regulator of GSK-3b, because Akt phosphorylates GSK-3b on this inhibitory serine residue. 34 However, several other kinases such as protein kinase C 35 and protein kinase A 36 can also phosphorylate this regulatory serine. The activity of GSK-3b is inversely related to the phosphorylation status of Ser-9. Dephosphorylation of this site, or mutations that prevent phosphorylation, leads to the activation of GSK-3b. 25 In the present investigation, dephosphorylation of the Ser-9 residue increased the kinase activity of GSK-3b, an effect that was mimicked by proteolytic treatment of GSK-3b with MMP-2. However, MMP-2-mediated proteolysis of GSK-3b dephosphorylated with l-phosphatase did not further increase the kinase activity as seen with MMP-2 cleaved native GSK-3b. Mass spectrophotometric analysis of the MMP-2-mediated cleavage of GSK-3b and experiments using N-terminal GST-tagged GSK-3b clearly suggest that MMP-2 cleaves the N-terminal region of GSK-3b which includes the inhibitory Ser-9 residue.
A recent study reported the proteolytic cleavage of GSK-3b by the Ca 2þ -dependant protease calpain-1, in which calpain-1 treatment was shown to augment the kinase activity of GSK-3b in mouse brain extracts. 18 It is now becoming evident that MMP-2 either targets a similar subset of proteins as calpain does or calpain may have been, in some instances, incorrectly identified as the protease responsible for such intracellular proteolytic activity. Indeed much of the evidence for calpain degradation of substrates in cardiac cells rests on the use of calpain inhibitors such as calpastatin which we have found to be able to inhibit MMP-2 activity (R. Schulz, unpublished results). Indeed there is controversy as to the exact role of calpains in acute myocardial ischaemia-reperfusion injury (stunning). 37 Interestingly, a recent study of a-myosin heavy chain promoter calpain-1 transgenic mice showed no evidence of troponin I degradation, 38 whereas troponin I levels were reduced in hearts from transgenic mice with myocardial-specific overexpression of constitutively active MMP-2. 7 We further sought to investigate the role of oxidative stress on the MMP-2-mediated alterations in GSK-3b in H9c2 cardiomyoblasts. It has recently been shown that oxidative stress stimulus increases MMP-2 transcription and activity in these cell lines. 22 H 2 O 2 is a reactive oxygen species that causes cardiac dysfunction. 39 In agreement with previous reports which utilized endothelial cells and fibroblasts 19, 40 H 2 O 2 challenge of H9c2 cardiomyoblasts for 5 h exhibited increased protein levels as well as gelatinolytic activity of MMP-2. Furthermore, H 2 O 2 treatment significantly decreased GSK-3b protein levels, and this decrease corresponded to increased GSK-3b kinase activity, similar to the effect of MMP-2 on GSK-3b as observed in the in vitro incubation assays. Both effects of H 2 O 2 on GSK-3b protein level and activity were abrogated by two structurally distinct MMP inhibitors, GM-6001 or ONO-4187. Co-immunoprecipitation experiments suggest that MMP-2 is indeed associated with GSK-3b in intact H9c2 cells.
The results from the current study are interesting to compare with the findings of Zhang et al. 41 who reported that intracerebroventricular administration of the peroxynitrite donor SIN-1 increased GSK-3b activity in the rat brain. In our previous studies, in isolated rat hearts, we have shown that the rapid activation of MMP-2 which was observed within 10 min of peroxynitrite infusion. 11 Hence, it is reasonable to predict that peroxynitrite may mediate its earliest cascade of damaging effects through activation of MMP-2 within the cardiomyocyte and subsequent proteolysis of susceptible intracellular targets. In the present investigation, we have demonstrated that increased GSK-3b activity is observed as a result of activated MMP-2 by oxidative stimuli like H 2 O 2 .
In conclusion, the present data indicate that GSK-3b may be another target of MMP-2 and that its cleavage by MMP-2 enhances GSK-3b kinase activity. Proteomic analysis and studies with N-terminal GST-tagged GSK-3b suggest that MMP-2 may cleave off the N-terminal of GSK-3b where the inhibitory phosphorylation of Ser-9 occurs. Hence, this MMP-2-mediated augmentation of GSK-3b kinase activity may contribute to cardiac dysfunction observed as a result of oxidative stress injury. 
